All Stories

  1. Real-life impact of weight in severe eosinophilic asthma patients treated with benralizumab

    Article • September 2021, European Respiratory Society (ERS)

    Francesco Menzella

  2. A case of chronic eosinophilic pneumonia in a patient treated with dupilumab

    Article • Therapeutics and Clinical Risk Management, July 2019, Dove Medical Press

    Francesco Menzella

  3. Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy?

    Article • Expert Opinion on Biological Therapy, May 2019, Taylor & Francis

    Francesco Menzella, Enrico Heffler

  4. Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for “Omics” Technology?

    Article • BioMed Research International, June 2018, Hindawi Publishing Corporation

    Francesco Menzella

  5. Towards precision medicine: The application of omics technologies in asthma management

    Article • F1000Research, April 2018, Faculty of 1000, Ltd.

    Francesco Menzella

  6. Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?

    Article • Journal of Asthma and Allergy, August 2017, Dove Medical Press

    Francesco Menzella